Literature DB >> 26121313

Prostaglandin E2 increases proximal tubule fluid reabsorption, and modulates cultured proximal tubule cell responses via EP1 and EP4 receptors.

Rania Nasrallah1, Ramzi Hassouneh1, Joseph Zimpelmann1, Andrew J Karam1, Jean-Francois Thibodeau1,2, Dylan Burger1,2, Kevin D Burns1,2, Chris Rj Kennedy1,2, Richard L Hébert1.   

Abstract

Renal prostaglandin (PG) E2 regulates salt and water transport, and affects disease processes via EP1-4 receptors, but its role in the proximal tubule (PT) is unknown. Our study investigates the effects of PGE2 on mouse PT fluid reabsorption, and its role in growth, sodium transporter expression, fibrosis, and oxidative stress in a mouse PT cell line (MCT). To determine which PGE2 EP receptors are expressed in MCT, qPCR for EP1-4 was performed on cells stimulated for 24 h with PGE2 or transforming growth factor beta (TGFβ), a known mediator of PT injury in kidney disease. EP1 and EP4 were detected in MCT, but EP2 and EP3 are not expressed. EP1 was increased by PGE2 and TGFβ, but EP4 was unchanged. To confirm the involvement of EP1 and EP4, sulprostone (SLP, EP1/3 agonist), ONO8711 (EP1 antagonist), and EP1 and EP4 siRNA were used. We first show that PGE2, SLP, and TGFβ reduced H(3)-thymidine and H(3)-leucine incorporation. The effects on cell-cycle regulators were examined by western blot. PGE2 increased p27 via EP1 and EP4, but TGFβ increased p21; PGE2-induced p27 was attenuated by TGFβ. PGE2 and SLP reduced cyclinE, while TGFβ increased cyclinD1, an effect attenuated by PGE2 administration. Na-K-ATPase α1 (NaK) was increased by PGE2 via EP1 and EP4. TGFβ had no effect on NaK. Additionally, PGE2 and TGFβ increased fibronectin levels, reaching 12-fold upon co-stimulation. EP1 siRNA abrogated PGE2-fibronectin. PGE2 also increased ROS generation, and ONO-8711 blocked PGE2-ROS. Finally, PGE2 significantly increased fluid reabsorption by 31 and 46% in isolated perfused mouse PT from C57BL/6 and FVB mice, respectively, and this was attenuated in FVB-EP1 null mice. Altogether PGE2 acting on EP1 and EP4 receptors may prove to be important mediators of PT injury, and salt and water transport.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26121313     DOI: 10.1038/labinvest.2015.79

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  51 in total

1.  Hypertonicity increases sodium transporters in cortical collecting duct cells independently of PGE2.

Authors:  Rania Nasrallah; Geneviève Paris; Richard L Hébert
Journal:  Biochem Biophys Res Commun       Date:  2012-01-12       Impact factor: 3.575

Review 2.  Renal fibrosis: new insights into the pathogenesis and therapeutics.

Authors:  Youhua Liu
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

3.  Endothelial microparticle formation by angiotensin II is mediated via Ang II receptor type I/NADPH oxidase/ Rho kinase pathways targeted to lipid rafts.

Authors:  Dylan Burger; Augusto C Montezano; Nobuhiro Nishigaki; Ying He; Anthony Carter; Rhian M Touyz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-05-19       Impact factor: 8.311

4.  Regulation of renal proximal tubule Na-K-ATPase by prostaglandins.

Authors:  Maryann B Herman; Trivikram Rajkhowa; Facundo Cutuli; James E Springate; Mary Taub
Journal:  Am J Physiol Renal Physiol       Date:  2010-02-03

5.  Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.

Authors:  I Reynisdóttir; K Polyak; A Iavarone; J Massagué
Journal:  Genes Dev       Date:  1995-08-01       Impact factor: 11.361

6.  Upregulation of cytosolic NADP+-dependent isocitrate dehydrogenase by hyperglycemia protects renal cells against oxidative stress.

Authors:  Soh-Hyun Lee; Sun-Ok Ha; Ho-Jin Koh; KilSoo Kim; Seon-Min Jeon; Myung-Sook Choi; Oh-Shin Kwon; Tae-Lin Huh
Journal:  Mol Cells       Date:  2009-12-08       Impact factor: 5.034

Review 7.  Chronic kidney disease: targeting prostaglandin E2 receptors.

Authors:  Rania Nasrallah; Ramzi Hassouneh; Richard L Hébert
Journal:  Am J Physiol Renal Physiol       Date:  2014-06-25

Review 8.  Prostanoids in health and disease.

Authors:  Emer M Smyth; Tilo Grosser; Miao Wang; Ying Yu; Garret A FitzGerald
Journal:  J Lipid Res       Date:  2008-12-17       Impact factor: 5.922

9.  Characterization of the PGI2/IP system in cultured rat mesangial cells.

Authors:  Rania Nasrallah; Anne Landry; James W Scholey; Richard L Hébert
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2004-05       Impact factor: 4.006

10.  PTGER1 deletion attenuates renal injury in diabetic mouse models.

Authors:  Jean-François Thibodeau; Rania Nasrallah; Anthony Carter; Ying He; Rhian Touyz; Richard L Hébert; Christopher R J Kennedy
Journal:  Am J Pathol       Date:  2013-10-08       Impact factor: 4.307

View more
  14 in total

Review 1.  PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes.

Authors:  Rania Nasrallah; Ramzi Hassouneh; Richard L Hébert
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

Review 2.  A Review of Prostanoid Receptors: Expression, Characterization, Regulation, and Mechanism of Action.

Authors:  Roger G Biringer
Journal:  J Cell Commun Signal       Date:  2020-09-24       Impact factor: 5.782

3.  Renal proximal tubule Na,K-ATPase is controlled by CREB-regulated transcriptional coactivators as well as salt-inducible kinase 1.

Authors:  Mary Taub; Sudha Garimella; Dongwook Kim; Trivikram Rajkhowa; Facundo Cutuli
Journal:  Cell Signal       Date:  2015-10-09       Impact factor: 4.315

4.  PGE2 EP1 receptor inhibits vasopressin-dependent water reabsorption and sodium transport in mouse collecting duct.

Authors:  Rania Nasrallah; Joseph Zimpelmann; David Eckert; Jamie Ghossein; Sean Geddes; Jean-Claude Beique; Jean-Francois Thibodeau; Chris R J Kennedy; Kevin D Burns; Richard L Hébert
Journal:  Lab Invest       Date:  2017-12-18       Impact factor: 5.662

5.  Deficiency of mPGES-1 exacerbates renal fibrosis and inflammation in mice with unilateral ureteral obstruction.

Authors:  Renfei Luo; Yutaka Kakizoe; Feifei Wang; Xiang Fan; Shan Hu; Tianxin Yang; Weidong Wang; Chunling Li
Journal:  Am J Physiol Renal Physiol       Date:  2016-10-26

Review 6.  Roles of EP Receptors in the Regulation of Fluid Balance and Blood Pressure.

Authors:  Lu Wang; Yiqian Wu; Zhanjun Jia; Jing Yu; Songming Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

7.  EP1 receptor antagonism mitigates early and late stage renal fibrosis.

Authors:  Jean-Claude Kresse; Henricus A M Mutsaers; Michael Schou Jensen; Stine Julie Tingskov; Mia Gebauer Madsen; Lene N Nejsum; Helle Praetorius; Rikke Nørregaard
Journal:  Acta Physiol (Oxf)       Date:  2022-01-30       Impact factor: 7.523

8.  Increased urinary prostaglandin E2 metabolite: A potential therapeutic target of Gitelman syndrome.

Authors:  Xiaoyan Peng; Lanping Jiang; Chen Chen; Yan Qin; Tao Yuan; Ou Wang; Xiaoping Xing; Xuemei Li; Min Nie; Limeng Chen
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

Review 9.  Atrial Natriuretic Peptide31-67: A Novel Therapeutic Factor for Cardiovascular Diseases.

Authors:  Gustavo Jose Justo da Silva; Raffaele Altara; George W Booz; Alessandro Cataliotti
Journal:  Front Physiol       Date:  2021-07-08       Impact factor: 4.566

10.  Prostaglandin E2 promotes human CD34+ cells homing through EP2 and EP4 in vitro.

Authors:  Yaqun Wang; Shuping Lai; Jing Tang; Chun Feng; Fangjie Liu; Chang Su; Waiyi Zou; Huizhen Chen; Duorong Xu
Journal:  Mol Med Rep       Date:  2017-05-30       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.